Insightful Word
  • Investing
  • Stock
  • Economy
  • Politics
  • Investing
  • Stock
  • Economy
  • Politics
No Result
View All Result
Insightful Word
No Result
View All Result
Home Stock

Sanofi says tolebrutinib drug delayed progressive MS by 31%

admin by admin
September 20, 2024
in Stock
0
Sanofi says tolebrutinib drug delayed progressive MS by 31%
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

FRANKFURT (Reuters) – Sanofi (NASDAQ:SNY) said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a progressive form of the disease by 31%, as the French drugmaker eyes a request for approval later this year.

The company said earlier this month that the late-stage trial with the drug candidate tolebrutinib was successful.

This post appeared first on investing.com

Previous Post

China’s August youth jobless rate rises to nine-month high

Next Post

US stock index futures consolidate after strong gains; FedEx slides

admin

admin

Next Post
US stock index futures consolidate after strong gains; FedEx slides

US stock index futures consolidate after strong gains; FedEx slides

Trending News

Former employees share key contrasts between Amazon & Google

Former employees share key contrasts between Amazon & Google

November 17, 2024
Alibaba stock rebound is elusive, but a comeback is coming in 2025

Alibaba stock rebound is elusive, but a comeback is coming in 2025

December 26, 2024
Raydium outshines Uniswap as RAY breakout signals continued gains

Raydium outshines Uniswap as RAY breakout signals continued gains

December 11, 2024
Subscribe to Insightful Word


    Recent News

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    August 7, 2025
    Affirm stock price is rising: is it a buy before earnings?

    Affirm stock price is rising: is it a buy before earnings?

    August 7, 2025
    Intel stock plunges sharply after Trump calls on CEO to resign: here’s why rebound may take time

    Intel stock plunges sharply after Trump calls on CEO to resign: here’s why rebound may take time

    August 7, 2025
    Goldman Sachs boosts Nvidia price target to $200 ahead of Q2 earnings

    Goldman Sachs boosts Nvidia price target to $200 ahead of Q2 earnings

    August 7, 2025

    Recent News

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    August 7, 2025
    Affirm stock price is rising: is it a buy before earnings?

    Affirm stock price is rising: is it a buy before earnings?

    August 7, 2025

    Latest News

    • Dow futures soar 250 points today: 5 things to know before Wall Street opens
    • Affirm stock price is rising: is it a buy before earnings?
    • Intel stock plunges sharply after Trump calls on CEO to resign: here’s why rebound may take time

    About Insightful Word

    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools
    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools

    Copyright © 2025 Insightfulword.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Politics

    Copyright © 2025 Insightfulword.com. All Rights Reserved.